These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6520122)

  • 1. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD).
    Tsuji S; Ohno T; Miyatake T; Suzuki A; Yamakawa T
    J Biochem; 1984 Oct; 96(4):1241-7. PubMed ID: 6520122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
    Street JM; Singh H; Poulos A
    Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
    Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
    J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; van den Bosch H; Schram AW; Tager JM
    Biochem Biophys Res Commun; 1988 Jun; 153(2):618-24. PubMed ID: 3382393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
    Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
    Rizzo WB; Avigan J; Chemke J; Schulman JD
    Neurology; 1984 Feb; 34(2):163-9. PubMed ID: 6538003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological significance of fatty acid elongation system in adrenoleukodystrophy.
    Koike R; Tsuji S; Ohno T; Suzuki Y; Orii T; Miyatake T
    J Neurol Sci; 1991 Jun; 103(2):188-94. PubMed ID: 1880537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exogenous monounsaturated fatty acids on fatty acid metabolism in cultured skin fibroblasts from adrenoleukodystrophy patients.
    Wilson R; Tocher DR; Sargent JR
    J Neurol Sci; 1992 Jun; 109(2):207-14. PubMed ID: 1634904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
    Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
    J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
    Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmalogen deficiency in cultured skin fibroblasts from neonatal adrenoleukodystrophy.
    Sakai T; Antoku Y; Goto I
    Exp Neurol; 1986 Oct; 94(1):149-54. PubMed ID: 3758277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
    Singh I; Moser AE; Goldfischer S; Moser HW
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical evidence for clinically diagnosed adrenoleucodystrophy in two brothers.
    Pretorius PJ; Reinecke CJ; Op't Hof J
    S Afr Med J; 1984 May; 65(21):860-2. PubMed ID: 6729621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.